Archives

New paper from the González’s lab

Bellinzona 13.04.2021 – A paper from the González’s lab studies how to modify the innate immune response to improve the adaptive immunity against a potential HIV vaccine. To study this mechanism, we have employed the revolutionary intravital 2-photon imaging available at the IRB in Bellinzona. Using this technique, we have studied the role of a […]

A single new weapon against multiple viruses transmitted by ticks

Bellinzona, 08.04.2021 – The bite of a tick can transmit Tick-Borne Encephalitis Virus (TBEV), which can cause brain infection, hospitalisation and long term neurologic problems. TBEV is only one among half a dozen viruses that ticks can transmit, causing for instance fulminant encephalitis (brain infection) or haemorrhagic disease (bleedings) for which there is no effective […]

Antiviral roles of CD8+ T cell in SIV and HIV infection

From: Georgia Research Alliance Eminent Scholar in Comparative Pathology, Professor & Chair, Department of Pathology and Laboratory Medicine, Emory University School of Medicine; Chief, Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta USA Host contact: Mariagrazia Uguccioni Date: 22.04.2021 16:00 Speakers: Guido Silvestri Virtual Conference

The IRB joins international network for the study of emerging infectious diseases

23.02.2021 – The IRB announces it has joined the United World Antiviral Research Network (UWARN), the organisation that brings together researchers from leading institutions in several countries around the globe to spot and confront emerging pandemic viruses. The participation in this initiative will enable the IRB (an affiliated institute of USI Università della Svizzera italiana) […]

DNA-Based Ligands and Receptors for Immune Cell Signaling

From: Professor, Dept. of Cellular and Molecular Pharmacology, University of California San Francisco, Investigator, Howard Hughes Medical Institute Host contact: Andrea Cavalli Date: 11.02.2021 14:00 Speakers: Ronald D. Vale, PhD Virtual Conference

Second generation antibody protects from SARS-CoV-2, its variant and prevents it from mutating to resist therapy

Bellinzona, 25.01.2021 – The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation ‘double antibody’ that protects from SARS-CoV-2, the virus causing COVID-19, and all its tested variants. It also prevents the virus from mutating to resist the therapy. Antibody-based immunotherapy was already shown to […]

COVID-19, study shows effectiveness of protective measures in hospitals in Ticino

A study performed in Ticino in Spring 2020, on data of SARS-CoV-2 serological tests run on healthcare workers, shows that COVID-19 antibodies are detectable in up to 10% of the participants. Such a result are comparable with the ones of the Corona Immunitas study conducted on the Ticino population. More importantly, it shows that healthcare […]

New Ebolavirus treatment sees the light thanks to basic research performed in Ticino

While populations around the world are being vaccinated against SARS-CoV-2, the U.S. Food and Drug Administration has announced the approval of a treatment against another well-known virus, much less widespread but extremely lethal: Ebola. The new drug was made possible thanks to the fundamental work performed at the laboratories of the Institute for Research in […]